MDH1 and rheumatoid arthritis: So by inhibiting MDH1 we can block the MAS and disrupt both the glycolytic pathway and TCA cycle which are considered essential metabolic pathways for immune cells in RA so in turn inhibition of MDH1 is considered an excellent target for inhibiting the proliferation and differentiation of different immune cells in RA and controlling the progression of RA.